Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of l-DOPA to rats

[1]  S. Fahn,et al.  The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain. , 1982, Life sciences.

[2]  C. Pycock,et al.  Behavioural and biochemical changes following chronic administration of L-dopa to rats. , 1982, European journal of pharmacology.

[3]  L. Thal,et al.  Age-related motor and catecholamine alterations in mice on levodopa supplemented diet. , 1981, Life sciences.

[4]  P. Jenner,et al.  Cation regulation differentiates specific binding of [3 H]sulpiride and [3 H]spiperone to rat striatal preparations , 1980, The Journal of pharmacy and pharmacology.

[5]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.

[6]  K. Wilner,et al.  Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy. , 1980, Biochemical pharmacology.

[7]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[8]  Y. Wong,et al.  Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors. , 1978, Life sciences.

[9]  B. Leonard,et al.  Isolation and assay of noradrenaline, dopamine, 5-hydroxy-tryptamine, and several metabolites from brain tissue using disposable bio-rad columns packed with sephadex G-10 , 1978 .

[10]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[11]  W. Weiner,et al.  Levodopa‐Induced dopamine receptor hypersensitivity , 1977, Transactions of the American Neurological Association.

[12]  A. Friedhoff,et al.  Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa. , 1977, Research communications in chemical pathology and pharmacology.

[13]  G. Chiara,et al.  Evidence for dopamine receptors mediating sedation in the mouse brain , 1976, Nature.

[14]  J. Korf,et al.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. , 1976, European journal of pharmacology.

[15]  P. Vonvoigtlander,et al.  Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. , 1975, The Journal of pharmacology and experimental therapeutics.

[16]  L. Iversen,et al.  The Action of Neuroleptic Drugs on Dopamine-Stimulated Adenosine Cyclic 3',5'-Monophosphate Production in Rat Neostriatum and Limbic Forebrain , 1974 .

[17]  M. Makman,et al.  Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[18]  U. Thendelenburg.  I. MECHANISMS OF SUPERSENSITIVITY AND SUBSENSITIVITY TO SYMPATHOMIMETIC AMINES , 1966 .

[19]  R. Laverty,et al.  MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN. , 1965, British journal of pharmacology and chemotherapy.